Home / Central Data Catalog / FRESH-PEF91-EN
central

Elaboration of a predictive clinical score to evaluate the adherence of obese, type 2 diabetic patient to the physician's recommendations in terms of medications, exercise and diet

France, 2008
Reference ID
FRESH-PEF91-en
Producer(s)
Franck;VIGNAL
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Feb 18, 2026
Last modified
Feb 18, 2026
Page views
72
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Data Access
  • Contacts

    • Identification

    Survey ID number

    FRESH-PEF91-en
    Title

    Elaboration of a predictive clinical score to evaluate the adherence of obese, type 2 diabetic patient to the physician's recommendations in terms of medications, exercise and diet
    Abbreviation or Acronym

    MELODIE
    Country
    Name Country code
    France fr
    Kind of Data

    ['Clinical data','Participant-reported health data']
    Unit of Analysis

    Individuals

    Scope

    Topics
    Topic Vocabulary
    Endocrinology health theme
    Type 2 diabetes mellitus cim-11
    Obesity cim-11
    Behavioral determinants health determinant
    Keywords
    predictive score adhesion to the modifications in the therapeutic care of their life hygiene

    Coverage

    Universe

    {"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Man or woman over the age of 18 years; Type-2 diabetes treated via oral diabetes medication monotherapy; HbA1c ≥ 6.5%; BMI ≥ 30 kg/m2; Abdominal obesity defined according to the NCEP/ATPIII – 2001 criteria: waist > 88 cm for women and > 102 cm for men.","clusion_E":""}

    Producers and sponsors

    Primary investigators
    Name
    Franck;VIGNAL
    Producers
    Name Role
    SANOFI (FRANCE) sponsor
    Funding Agency/Sponsor
    Name
    AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE)

    Study authorization

    Agency
    Agency name
    CNIL
    CPP

    Sampling

    Sample frame

    Unit Type

    ['Through independent healthcare practitioners']
    Sampling Procedure

    ['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Access on specific project only
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    2008-01-01 2008-12-31
    Time Method

    One-time cross-sectional study
    Mode of data collection
    • {"concept":{"vocabURI":"Interview","vocab":"CESSDA"},"value":"Interview with the participant (including clinical)"}
    • {"concept":{"vocabURI":"Transcription","vocab":"CESSDA"},"value":"Converting or copying information into a structured record"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Health event/morbidity

    Data Access

    Availability Status

    {"value":"To be defined","extLink":[]}

    Contacts

    Contacts
    Name Email
    Franck;VIGNAL franck.vignal@sanofi.com
    Back to Catalog